Showing 4941-4950 of 5623 results for "".
- Sun Pharmaceutical Donates 2.5 Million Hydroxychloroquine Sulfate Tablets in the US For Potential COVID-19 Treatmenthttps://modernod.com/news/sun-pharmaceutical-donates-2-5-million-hydroxychloroquine-sulfate-tablets-in-the-us-for-potential-covid-19-treatment/2477480/Sun Pharmaceutical Industries announced that it has donated 2.5 million hydroxychloroquine sulfate tablets for use in the United States. Sun Pharma is seeking to enable health care experts meet the growing patient demands for this product as they assess its potential to treat COVID-19 through cli
- Zeiss Releases Company Update on COVID-19 Pandemichttps://modernod.com/news/zeiss-releases-company-update-on-covid-19-pandemic/2477475/In response to the spread of the novel coronavirus, Zeiss released a statement stating that it has developed comprehensive measures to protect employees and maintain smart business continuity. The statement reads: “In light of the current situation created by the COVID-19 pand
- Eyewire News Exclusive: Q&A With Anne Coleman, MD, PhD, President of AAOhttps://modernod.com/news/eyewire-news-exclusive-qa-with-anne-coleman-md-phd-president-of-aao/2477474/The American Academy of Ophthalmology (AAO) continues to update its guidance for ophthalmologists dealing with the COVID-19 pandemic. Most recently, AAO updated its guidance on vaccine and t
- European Glaucoma Society Postpones Annual Congresshttps://modernod.com/news/european-glaucoma-society-postpones-annual-congress/2477472/The Executive Committee of the European Glaucoma Society has decided to postpone the 14th EGS Congress in Brussels, Belgium to December due to the global COVID-10 pandemic. A statement posted on the EGS website read: “In these times of uncertainty, the first
- COVID-19 Roundtable: How Retina Doctors From Around the United States Are Adjusting Their Clinicshttps://modernod.com/news/covid-19-roundtable-how-retina-doctors-from-around-the-united-states-are-adjusting-their-clinics/2477467/Eyewire News checked in with four retina specialists in COVID-19 hotspots around the United States—Seattle, New York, Boston, and Orlando—to see how they are adjusting their clinics in light of the AAO’s latest guidance. To read a full summary of their adjustments, read the forthcoming April issu
- MicroSurgical Technology (MST) Announces the Acquisition of IP and Assets of IRISS Medical Technologies Limitedhttps://modernod.com/news/microsurgical-technology-mst-announces-the-acquisition-of-ip-and-assets-of-iriss-medical-technologies-limited/2477460/MicroSurgical Technology (MST) has acquired the IP and assets of IRISS Medical Technologies Limited, a United Kingdom private limited company, related to the Volk Eye Check product and additional technology and intellectual property. Terms of the deal were not disclosed. The Volk E
- American College of Surgeons Releases New Clinical Guidance Document For Elective Surgical Case Triage During COVID-19https://modernod.com/news/american-college-of-surgeons-releases-new-clinical-guidance-document-for-elective-surgical-case-triage-during-covid-19/2477456/To assist in surgical decision-making in curtailing cases, The American College of Surgeons (ACS) released “COVID-19: Elective Case Triage Guidelines for Surgical Care,” a new surgical triage document that was developed following expert review in several specialties and provides trust
- FDA Clamps Down On At-Home Coronavirus Testing, Citing Fake Products and Bad Actorshttps://modernod.com/news/fda-clamps-down-on-at-home-coronavirus-testing-citing-fake-products-and-bad-actors/2477444/After telling companies, laboratories and state health departments to move forward with emergency coronavirus testing without federal oversight or approval, the FDA is now working to rein in the ones it describes as going too far, according to a <
- FDA Approves Genentech’s Clinical Trial for Actemra to Treat Hospitalized Patients With Severe COVID-19 Pneumoniahttps://modernod.com/news/fda-approves-genentechs-clinical-trial-for-actemra-to-treat-hospitalized-patients-with-severe-covid-19-pneumonia/2477442/Genentech announced Monday that the FDA has approved a randomized, double-blind, placebo-controlled phase 3 clinical trial in collaboration with the Biomedical Advanced Research and Development Authority (BARDA) to evaluate the safety and efficacy of intravenous Actemra (tocilizumab) plus standar
- Coronavirus Vaccine Trials Could Start in UK Within a Monthhttps://modernod.com/news/coronavirus-vaccine-trials-could-start-in-uk-within-a-month/2477440/Trials of a coronavirus vaccine could begin within the next month, the UK’s health agency has said, as it prepares to start evaluating a drug developed by Oxford University, according to a report in The Telegraph. Scientists at Public Health England (PHE) could give the go-ahead for